Skip to content

Project for establishing control solutions for glucose measurement systems based on blood samples

Project for establishing control solutions for glucose measurement systems based on blood samples - IfDT-2406-IU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034618
Enrollment
50
Registered
2024-07-23
Start date
2024-07-24
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No specific disease is investigated. The aim of the study is the production of universally applicable whole blood control samples that can be used, for example, for external quality control of glucose measurement systems.

Interventions

Group 1: In this study, blood is taken from the vein of the arm. Part of the blood is used to obtain a blood count with determination of various laboratory values and an additional test for hepatitis

Sponsors

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - You have to be able to understand the study plan and willing to follow the study procedures - Signed informed consent form

Exclusion criteria

Exclusion criteria: - Known infection with hepatitis B, C or HIV - Female participants: pregnancy (as determined by urine pregnancy test), lactation period - Known anemia or iron deficiency - Serious acute or chronic disease or an anamnesis that, in the opinion of investigator, could pose a risk to the participant, e.g., seizure disorder, adrenal disorder, dialysis for renal failure, cystic fibrosis, acute infection - Intake of oxidizing substances - Known coagulation disorder - Any incapacity or general condition that, in the opinion of the investigator, prevents adequate compliance with study procedures, e.g., mental or visual incapacity, language barriers, alcohol or drug abuse

Design outcomes

Primary

MeasureTime frame
Reproducibility of glucose measurement results that have been obtained with range of glucose measurement systems. This assessment will be done for each system and each concentration level separately.

Secondary

MeasureTime frame
The following exploratory endpoints are currently planned: • Donor variability • Differences between measurement systems

Countries

Germany

Contacts

Public ContactStefan Pleus

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)

stefan.pleus@idt-ulm.de+49 731 509900

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026